To view this email as a web page, click here.

 
PHARMACISTS' REPORT
 
Weigh in: Should states still allow vaccination exemptions for either religious or philosophical reasons?
Take part in a Drug Topics poll!
Read more
 
ADVERTISEMENT
Compliance Handbook: three critical laws that govern your pharmacy
Get an in-depth look at the FDA, DEA, and EPA regulations pertaining to the security of the drug supply chain, the regulation of controlled substances and the management of pharmaceutical hazardous waste. Download the Compliance Handbook from Pharma Logistics today.
 
Telepharmacy’s New Frontiers Expand Business Opportunities
Rural markets pave the way to treat underserved populations, provide value-based career and expand prescription volume.
Read more
 
ADVERTISEMENT
PHARMACY OWNERS FOCUSING ON BUSINESS VALUATION
In an era of declining revenues and margins, independent pharmacy owners are focusing their business efforts and skills on enhancing store values. Owners of independent stores engaged in exit strategy and ownership transition planning agree that the first step in these processes is to determine an accurate, reality-based fair market value of their businesses. Legacy rules of thumb no longer apply when valuing independent pharmacies. Learn more
 
Sunosi (Solriamfetol) Approved for Excessive Daytime Sleepiness in Adults
Solriamfetol is approved for adult patients suffering from the effects of narcolepsy and OSA.
Read more
 
ADVERTISEMENT
Can you increase volume and keep patients happy?
Workflow management isn't just tighter coordination or more economical use of space. It's a business-changing boost to employee productivity. Learn how four pharmacies found an answer to better workflow. Read More
 
New Research Aims to Combat Flu Pandemics
Researchers are targeting the receptors the virus uses to enter the body.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.